(+)-myristinins A and D from Knema elegans, which inhibit DNA polymerase β and cleave DNA

被引:52
作者
Deng, JZ [1 ]
Starck, SR [1 ]
Li, SS [1 ]
Hecht, SM [1 ]
机构
[1] Univ Virginia, Dept Biol & Chem, Charlottesville, VA 22903 USA
来源
JOURNAL OF NATURAL PRODUCTS | 2005年 / 68卷 / 11期
关键词
D O I
10.1021/np058064g
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
A survey of crude plant extracts for DNA polymerase inhibitors resulted in the identification of a methyl ethyl ketone extract prepared from Knema elegans that strongly inhibited the enzyme. Subsequent bioassay-guided fractionation of the extract, using an assay to monitor the activity of DNA polymerase beta, led to the isolation of two potent inhibitors, (+)-myristinins A (1) and D (2), which are known flavans having unusual structures. (+)-Myristinins A and D exhibited IC50 values of 12 and 4.3 mu M, respectively, as inhibitors of DNA polymerase beta in the presence of bovine serum albumin (BSA), and 2.7 and 1:2 mu M in the absence of BSA. As such, they are the most potent DNA polymerase inhibitors reported to date. Compounds 1 and 2 potentiated the cytotoxicity of bleomycin toward cultured P388D(1) cells, reducing the number of viable cells by at least 30% when employed at 9 mu M concentration for 6 h in the presence of an otherwise nontoxic concentration of bleomycin (75 nM). Principles 1 and 2 also induced strong Cu2+-dependent DNA strand scission in a DNA cleavage assay. Accordingly, 1 and 2 exhibit two activities, namely, DNA polymerase beta inhibition and DNA damage.
引用
收藏
页码:1625 / 1628
页数:4
相关论文
共 46 条
[1]   EXPRESSION OF HUMAN DNA POLYMERASE-BETA IN ESCHERICHIA-COLI AND CHARACTERIZATION OF THE RECOMBINANT ENZYME [J].
ABBOTTS, J ;
SENGUPTA, DN ;
ZMUDZKA, B ;
WIDEN, SG ;
NOTARIO, V ;
WILSON, SH .
BIOCHEMISTRY, 1988, 27 (03) :901-909
[2]  
AKIRA M, 1992, J PHARMACOL EXP THER, V263, P1302
[3]   ENHANCED REPAIR OF A CISPLATIN-DAMAGED REPORTER CHLORAMPHENICOL-O-ACETYLTRANSFERASE GENE AND ALTERED ACTIVITIES OF DNA-POLYMERASES ALPHA AND BETA, AND DNA-LIGASE IN CELLS OF A HUMAN-MALIGNANT GLIOMA FOLLOWING IN-VIVO CISPLATIN THERAPY [J].
ALIOSMAN, F ;
BERGER, MS ;
RAIRKAR, A ;
STEIN, DE .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 54 (01) :11-19
[4]  
Beard WA, 1995, METHOD ENZYMOL, V262, P98
[5]   SYNTHESIS OF CONDENSED TANNINS .1. STEREOSELECTIVE AND STEREOSPECIFIC SYNTHESES OF OPTICALLY PURE 4-ARYLFLAVAN-3-OLS, AND ASSESSMENT OF THEIR ABSOLUTE STEREOCHEMISTRY AT C-4 BY MEANS OF CIRCULAR-DICHROISM [J].
BOTHA, JJ ;
YOUNG, DA ;
FERREIRA, D ;
ROUX, DG .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1981, (04) :1213-1219
[6]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109
[7]   Overexpression of DNA polymerase β in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs [J].
Canitrot, Y ;
Cazaux, C ;
Fréchet, M ;
Bouayadi, K ;
Lesca, C ;
Salles, B ;
Hoffmann, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12586-12590
[8]   DNA repair: Enzymatic mechanisms and relevance to drug response [J].
Chaney, SG ;
Sancar, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (19) :1346-1360
[9]   Inhibitors of DNA polymerase β from Schoepfia californica [J].
Chen, J ;
Zhang, YH ;
Wang, LK ;
Sucheck, SJ ;
Snow, AM ;
Hecht, SM .
CHEMICAL COMMUNICATIONS, 1998, (24) :2769-2770
[10]   EXPRESSION OF ACTIVE-RAT DNA POLYMERASE-BETA IN ESCHERICHIA-COLI [J].
DATE, T ;
YAMAGUCHI, M ;
HIROSE, F ;
NISHIMOTO, Y ;
TANIHARA, K ;
MATSUKAGE, A .
BIOCHEMISTRY, 1988, 27 (08) :2983-2990